Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Chinese Patent Office
Colorcon
Dow
Healthtrust
Chubb
Citi
Queensland Health
Farmers Insurance

Generated: June 22, 2018

DrugPatentWatch Database Preview

STRONTIUM CHLORIDE SR-89 Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Strontium Chloride Sr-89 patents expire, and when can generic versions of Strontium Chloride Sr-89 launch?

Strontium Chloride Sr-89 is a drug marketed by Bio Nucleonics and is included in one NDA.

The generic ingredient in STRONTIUM CHLORIDE SR-89 is strontium chloride sr-89. There are sixteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the strontium chloride sr-89 profile page.
Drug patent expirations by year for STRONTIUM CHLORIDE SR-89
Synonyms for STRONTIUM CHLORIDE SR-89
5R78837D4A
AC1L1VEK
AC1L2G5Z
AC1NSFZJ
AC1NTUP5
AC1Q232M
ACMC-20ajmr
AHBGXTDRMVNFER-UHFFFAOYSA-L
AKOS030228140
CHEBI:36383
CHEMBL1200625
CHEMBL2219640
CTK0H6760
D0R6HN
DB09498
Dichlorostrontium
DTXSID10191655
DTXSID6040616
EKE8PS9J6Z
FT-0689177
IN015427
J-001249
KS-00000YRS
KSC176O6B
Metastron
MolPort-006-119-579
RT-000453
SC-79408
SMS-2PA
SMS2PA
Strontium (89Sr) chloride
STRONTIUM CHLORIDE
Strontium Chloride (89Sr)
Strontium chloride Sr 89
Strontium chloride Sr 89 [USAN:USP]
Strontium Chloride, Anhydrous
Strontium dichloride
strontium-89(2+) dichloride
Strontium(II) chloride
strontiumdichlorid

US Patents and Regulatory Information for STRONTIUM CHLORIDE SR-89

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bio Nucleonics STRONTIUM CHLORIDE SR-89 strontium chloride sr-89 INJECTABLE;INJECTION 075941-001 Jan 6, 2003 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Medtronic
Dow
Teva
Harvard Business School
Julphar
Chubb
Express Scripts
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.